Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01216722 · ClinicalTrials.gov registry record · NA

Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant

A NA study of Liver Transplantation and Resistance Training, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT01216722 is a NA study of Liver Transplantation and Resistance Training that has completed, run by University of Miami. The registered enrollment target is 52 participants, below the 319-participant average among 12 other Liver Transplantation trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01216722, a NA study of Liver Transplantation and Resistance Training, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

Resistance strengthening exercise will increase strength and functional activity greater than ambulation in subjects post-liver transplantation.

Interventions

  • OTHER Resistance Strengthening Exercise Program

Study Locations (1)

Florida

  • University of Miami Department of Physical Therapy - Coral Gables

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2007-10
Est. Completion 2010-07
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT01216722

The ClinicalTrials.gov registry entry for NCT01216722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 319-participant average among 12 other Liver Transplantation trials with a reported enrollment target (84% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Liver Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Resistance Strengthening Exercise Program is the first listed.

NCT01216722 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01216722 about?

NCT01216722 is a clinical study titled "Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant". Resistance strengthening exercise will increase strength and functional activity greater than ambulation in subjects post-liver transplantation.

What is the current status of trial NCT01216722?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2007-10. Estimated completion is 2010-07.

What conditions does trial NCT01216722 study?

This clinical trial studies the following conditions: Liver Transplantation, Resistance Training, Activities of Daily Living.

What interventions are being tested in trial NCT01216722?

The interventions under investigation include: Resistance Strengthening Exercise Program (OTHER).

Who is sponsoring clinical trial NCT01216722?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01216722 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.